Evidence map›Paper›PMID 40697621›Full record

ArticleOsteoarthritis and cartilage open2025

Protocol for the comparison of remote versus face-to-face osteoarthritis management programs (COASTAL): A randomized implementation trial.

Shiwen Yuan, Jocelyn L Bowden, Jillian P Eyles, Vicky Duong, Stephen Messier, Elena Losina, Jean Frederic Levesque, Andrew M Briggs, Michelle M Dowsey, Leticia Alle Deveza and 20 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Osteoarthritis and cartilage open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Shiwen YuanSydney Musculoskeletal Health, Kolling Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Jocelyn L BowdenSydney Musculoskeletal Health, Kolling Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Jillian P EylesSydney Musculoskeletal Health, Kolling Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Vicky DuongSydney Musculoskeletal Health, Kolling Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Stephen MessierWake Forest University, Winston-Salem, North Carolina, USA.
Elena LosinaBrigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Jean Frederic LevesqueNSW Agency for Clinical Innovation, Sydney, NSW, Australia.
Andrew M BriggsCurtin School of Allied Health, Curtin University, Perth, WA, Australia.
Michelle M DowseyUniversity of Melbourne Department of Surgery, St. Vincent's Hospital, Fitzroy, VIC, Australia.
Leticia Alle DevezaSydney Musculoskeletal Health, Kolling Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Nicole M RankinMelbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, VIC, Australia.
Christian J BartonDepartment of Physiotherapy, Podiatry and Prosthetics and Orthotics, School of Allied Health Human Services and Sport, La Trobe University, Melbourne, VIC, Australia.
Blake F DearSchool of Psychological Sciences, Macquarie University, Sydney, NSW, Australia.
Carin PrattNorthern Sydney Local Health District, Royal North Shore Hospital, Sydney, NSW, Australia.
Jonathan SmithersArthritis Australia, Sydney, NSW, Australia.
Louise HardyArthritis Australia, Sydney, NSW, Australia.
Caroline BillsHealthChange Associates, Melbourne, Vic, Australia.
Julia ThompsonNSW Agency for Clinical Innovation, Sydney, NSW, Australia.
Tom ButtelConsumer Investigator, Sydney, NSW, Australia.
Daniel EwaldUniversity Centre for Rural Health School of Medicine, University of Sydney, Sydney, NSW, Australia.
Kevin ChengOsana, Sydney, NSW, Australia.
Nicola WareRamsay Health Research Foundation, Sydney, NSW, Australia.
Daniel RichardsonNorthern Sydney Local Health District, Hornsby Hospital, Sydney, NSW, Australia.
Erica MorganSouth Eastern Sydney Local Health District, The Sutherland Hospital, Sydney, NSW, Australia.
Monique StrelnikowSouthern NSW Local Health District, South East Regional Hospital. Bega, NSW, Australia.
Venkatesha VenkateshaNorthern Sydney Local Health District, Royal North Shore Hospital, Sydney, NSW, Australia.
Alexandra WarhurstRemedy Healthcare, Melbourne, VIC, Australia.
Vineeta KurienSydney Musculoskeletal Health, Kolling Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Scott CherySydney Musculoskeletal Health, Kolling Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
David J HunterSydney Musculoskeletal Health, Kolling Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To determine the comparative effectiveness of three evidence-informed approaches to delivering osteoarthritis (OA) care in real-world settings: face-to-face services, telehealth services or a mobile application (app). Design: COASTAL (ACTRN12624000996561) comprises two aims: the primary aim is a three-arm, non-inferiority, comparative-effectiveness, type I hybrid implementation RCT; and the secondary aim is a superiority trial to compare the three interventions separately to an untreated, non-randomized control group. We will recruit 1348 participants (primary aim:1011 interventions; secondary aim:1011 interventions, 337 controls) with knee OA referred to a NSW public Osteoarthritis Chronic Care Program (OACCP). Eligible participants who consent to OACCP participation will be randomized 1:1:1 to receive care through the face-to-face OACCP, a telehealth service, or the "OA Coach" app, over 6-months. All participants will receive a standardized needs assessment; OA education; collaboratively developed, personalized management plan with a focus on therapeutic exercise, physical activity, pain management, and weight-management, according to each arm's mode of delivery. People who have declined OACCP participation will be eligible for the control group. The primary outcome is change in average knee pain during walking at 6-months (11-point NRS). Secondary, implementation, and economic evaluation outcomes will be collected at 6 and 12-months.The protocol was co-developed with people with knee OA, clinicians delivering the services, and other stakeholders. Ethical approval granted by the Northern Sydney Local Health District (2024/ETH01461). Conclusion: The results of this trial will provide critical evidence to help people with OA, clinicians, service planners and policymakers choose between different modes of delivering care for knee OA.

Indexed as

ImplementationKneeManagement programsOsteoarthritisRandomized controlled trial

Identifiers

PMID40697621
PMCPMC12281381

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.